A randomized controlled study of omalizumab in children with moderate-to-severe persistent allergic asthma Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma Year: 2008
Nasal beclomethasone plus loratadine in patients with rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial Source: Eur Respir J 2007; 30: Suppl. 51, 547s Year: 2007
Prednisolone for preschool children presenting with acute wheeze: A multicentre RCT. Source: International Congress 2017 – Paediatric asthma: therapies and comorbidities Year: 2017
Airway hyperresponsiveness to mannitol as a predictor of treatment response to ciclesonide in patients with suspected asthma: A double-blind, randomised, placebo-controlled trial Source: Annual Congress 2012 - Bronchial challenge as a biomarker of respiratory disease Year: 2012
Intermittent montelukast or preschool wheeze, the results of a randomised controlled trial with stratification for ALOX5 promoter genotype Source: International Congress 2014 – Clinical Trial presentation and discussion "Cysteinyl leukotrienes and paediatric asthma: a new horizon or a blind alley?" Year: 2014
Does fluticasone or montelukast reduce the risk of recurency of wheezing bronchitis comparing to no intervention in children under the age of 3 Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010
A proof-of-concept randomized-controlled trial of omalizumab in patients with severe difficult to control nonatopic asthma Source: Annual Congress 2012 - Clinical diagnosis and treatment of adult asthma Year: 2012
Comparison of ciclesonide 160 μg/d with budesonide 400 μg/d in a randomised, double-blind study in children with moderate to severe asthma Source: Eur Respir J 2006; 28: Suppl. 50, 711s Year: 2006
Safety of formoterol in children and adolescents: experience from asthma clinical trials Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma Year: 2008
Randomized trial of HFA-salbutamol versus CFC-salbutamol via MDI with spacer for acute wheezing exacerbations in children less than 2 years of age Source: Eur Respir J 2002; 20: Suppl. 38, 430s Year: 2002
Pragmatic controlled trial of azithromycin for asthma in adults Source: Annual Congress 2011 - Phenotyping asthma: a clue for treatments? Year: 2011
Clinical disposition, safety and efficacy of fluticasone propionate (FP) in pre-school children with persistent wheeze and asthma-like symptoms Source: Eur Respir J 2002; 20: Suppl. 38, 219s Year: 2002
Efficacy of fluticasone on cough: a randomised controlled trial Source: Eur Respir J 2005; 25: 147-152 Year: 2005
Adherence to beclomethasone in children with persistent asthma in a low-income country: a randomized concurrent cohort study Source: Eur Respir J 2005; 26: Suppl. 49, 162s Year: 2005
Randomized, placebo-controlled study of asthmatic smokers treated with montelukast or mid-dose fluticasone Source: Annual Congress 2011 - Asthma management and response Year: 2011
Montelukast for toddler asthma? A meta-analysis of montelukast in preschool wheeze Source: International Congress 2016 – Paediatric asthma: lessons learned from studies with large sample sizes and multi-centre drug studies Year: 2016
Randomized, placebo-controlled studies of onset and duration of single-dose protection against exercise-induced bronchoconstriction (EIB) by montelukast Source: Eur Respir J 2005; 26: Suppl. 49, 254s Year: 2005
A multi-centre doubleblind randomised study examining the clinical outcome of treatment of the first asthma exacerbation with salmeterol xinafoate/fluticasone propionate combination product versus prednisolone Source: Eur Respir J 2003; 22: Suppl. 45, 287s Year: 2003
Efficacy of reslizumab in adults with severe eosinophilic asthma with =3 exacerbations in the previous year: analyses at weeks 16 and 52 of two placebo-controlled phase 3 trials Source: International Congress 2017 – Asthma epidemiology among children and adults: from biomarkers to ACOS Year: 2017
Using placebo-controlled trials to define predictors of future exacerbations in severe asthma patients Source: Eur Respir J, 58 (6) 2101702; 10.1183/13993003.01702-2021 Year: 2021